| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $1,895,400 ) |
| | 2022 | 2022 | VERANTOS, INC. | 325 SHARON PARK DR # 730 | MENLO PARK | CA | 94025-6805 | SAN MATEO | USA | U01FD007172 | Transforming Real-world evidence with Unstructured and Structured data to advance Tailored therapy (TRUST) | 000 | 3 | FDA | 8/23/2022 | $1,895,400 |
|
| Issue Date FY: 2021 ( Subtotal = $1,895,400 ) |
| | 2021 | 2021 | VERANTOS, INC. | 325 SHARON PARK DR # 730 | MENLO PARK | CA | 94025-6805 | SAN MATEO | USA | U01FD007172 | Transforming Real-world evidence with Unstructured and Structured data to advance Tailored therapy (TRUST) | 001 | 2 | FDA | 7/20/2021 | -$428,200 |
| | 2021 | 2021 | VERANTOS, INC. | 325 SHARON PARK DR # 730 | MENLO PARK | CA | 94025-6805 | SAN MATEO | USA | U01FD007172 | Transforming Real-world evidence with Unstructured and Structured data to advance Tailored therapy (TRUST) | 001 | 2 | FDA | 7/20/2021 | $428,200 |
| | 2021 | 2021 | VERANTOS, INC. | 325 SHARON PARK DR # 730 | MENLO PARK | CA | 94025-6805 | SAN MATEO | USA | U01FD007172 | Transforming Real-world evidence with Unstructured and Structured data to advance Tailored therapy (TRUST) | 000 | 2 | FDA | 7/14/2021 | $1,467,200 |
| | 2021 | 2021 | VERANTOS, INC. | 325 SHARON PARK DR # 730 | MENLO PARK | CA | 94025-6805 | SAN MATEO | USA | U01FD007172 | Transforming Real-world evidence with Unstructured and Structured data to advance Tailored therapy (TRUST) | 000 | 2 | FDA | 7/14/2021 | $428,200 |
|
| Issue Date FY: 2020 ( Subtotal = $1,895,400 ) |
| | 2020 | 2020 | VERANTOS, INC. | 325 SHARON PARK DR # 730 | MENLO PARK | CA | 94025-6805 | SAN MATEO | USA | U01FD007172 | Transforming Real-world evidence with Unstructured and Structured data to advance Tailored therapy (TRUST) | 000 | 1 | FDA | 9/8/2020 | $1,895,400 |
| | 2020 | 2019 | VERANTOS, INC. | 325 SHARON PARK DR # 730 | MENLO PARK | CA | 94025-6805 | SAN MATEO | USA | R44TR002437 | Leveraging advanced clinical phenotyping to enhance problem lists and support value-based healthcare | 000 | 4 | NIH | 2/28/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $1,349,229 ) |
| | 2019 | 2019 | VERANTOS, INC. | 325 SHARON PARK DR # 730 | MENLO PARK | CA | 94025-6805 | SAN MATEO | USA | R44TR002437 | Leveraging advanced clinical phenotyping to enhance problem lists and support value-based healthcare | 002 | 4 | NIH | 8/10/2019 | $749,614 |
| | 2019 | 2018 | VERANTOS, INC. | 325 SHARON PARK DR # 730 | MENLO PARK | CA | 94025-6805 | SAN MATEO | USA | R44TR002437 | Leveraging advanced clinical phenotyping to enhance problem lists and support value-based healthcare | 001 | 3 | NIH | 2/13/2019 | $599,615 |
|
|
